The incidence of papillary thyroid carcinoma (PTC), which is the most common histologic type of thyroid malignancy, is increasing worldwide [1]. High cure rates are achieved after initial treatment of patients who develop PTC. However, some patients are at a high risk of recurrence and even of death. Many publications have been devoted to finding prognostic factors for PTC, focusing on epidemiological, biological, clinical and pathological data [2-5].

In recent years, positive associations between height, weight and body mass index (BMI) and PTC have been reported [6-13]. The World Cancer Research Fund (WCRF) report concludes to a potential association between thyroid cancer and body size, possibly through changes in iodine requirement [14].

Most of these studies have looked into the etiology of thyroid cancer by comparing with healthy controls, however, it is unclear whether prognostic role of the body size in the severity and recurrence of PTC. Recently, Paes et al. [15] suggested that obesity may be correlated with a less aggressive tumor invasion, however it was not significant. Thus, more studies on effects of obesity for the thyroid cancer are needed.

In this study, we aimed to examine the association of indices of body size with aggressiveness and recurrence of PTC. So, we performed a retrospective investigation of the body size and cancer characteristics of patients who underwent total thyroidectomy PTC in our hospital.

We reviewed the charts of the persons who underwent a health examination from January 2007 to December 2009 in Health Examination Center of Gyeongsang National University. Among these, the patients who underwent total thyroidectomy for PTC were selected for the study. In each operation, when lymph node metastasis was suspected from the preoperative or intraoperative findings, central neck and/or lateral neck lymph node dissection were performed.

The epidemiologic factor and pathologic report after operation were determined based on chart review. Tumor-node-metastasis stage was based on the American Joint Committee on Cancer cancer staging manual seventh edition [16]. For each patients, the height and weight reported in the anesthesia summary was used to calculate the BMI according to its determined formula (i.e., BMI = weight [kg] / height [m²]).

All data are expressed as mean (± standard deviation). The SPSS (SPSS Inc., Chicago, IL, USA) was used for statistical analysis, and the one way analysis of variance test and chi-square test were used to compare the indices of body size and other parameters between T and N stage sub-groups.

Multivariate analysis was performed with logic regression analysis to identify the independent predictors of lymph node metastasis. P < 0.05 was considered statistically significant.

A total of 315 PTC patients (47 men and 268 women) were studied. The mean age was 51.09 years (range, 12 to 88 years). The mean BMI was 24.51 ± 3.20 kg/m² and 133 patients (42.2%) had a BMI same or higher than 25 kg/m². One hundred seventh-nine patients (56.8%) had nodules which were extrathyroidal extension, and 121 patients had regional lymph node metastasis (Table 1).

Recently many studies on the correlations between thyroid cancer and height, weight, and BMI have been published [6,11,17,18]. However, great heterogeneity exists among studies as to the actual association between body size and thyroid malignancy. The WCRF report concludes to a potential association between thyroid cancer and body size, possibly through changes in iodine requirement [14]. Renehan et al. [8] conducted a meta-analysis of five prospective studies on thyroid cancer and BMI, and reported that the risk of thyroid cancer for each increase of 5 in BMI among men and women were 1.52 and 1.14, respectively. According to a study by Sung et al. [18] on the development of various cancers by height, the greater the height, the higher the frequency of thyroid cancer became for both men and women.

Studies have been carried out on BMI and cancer risk, but the relationship between obesity and thyroid cancer stage or behavior remains unclear. Recently, Paes et al. [15] reported that a higher BMI was found not be associated with more aggressive tumor features or a greater likelihood of recurrence or persistence. Rather, they suggested that obesity may be correlated with a less aggressive tumor invasion, though it was not significant.

This study also found no statically significant difference between indices of body size and T and N stage. In neck lymph node metastasis, the group of positive metastasis had taller mean height, but there was no significant difference in multivariate analysis. Because the younger patients had an increased tendency to be taller than older patients, and the patients of positive lymph node metastasis were younger than the others.

Since this study was a retrospective study, it was limited in that various biases could not be excluded. This study was also limited in that it could not represent the patients who underwent lobectomy of the thyroid (small size and solitary cancer) since the subjects were only selected from patients who underwent total thyroidectomy among the PTC patients. Moreover, because this study had short period of follow-up and was carried out with a relatively small group of patients, the prognosis was not directly compared.

In this study, our findings suggest that PTC severity and recurrence are not associated with indices of body size. A further confirmatory study should be conducted.